Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.

Bibliographic Details
Main Authors: Santos Castañeda, Irene Llorente, Rosario García-Vicuña, Isidoro González-Álvaro
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Arthritis Research & Therapy
Online Access:http://link.springer.com/article/10.1186/s13075-017-1362-5
id doaj-1762fa9052c44187a3af3e1d5d38d78f
record_format Article
spelling doaj-1762fa9052c44187a3af3e1d5d38d78f2020-11-24T21:10:31ZengBMCArthritis Research & Therapy1478-63622017-07-011911210.1186/s13075-017-1362-5Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.Santos Castañeda0Irene Llorente1Rosario García-Vicuña2Isidoro González-Álvaro3Rheumatology Division, Hospital de La Princesa, IIS-IP, Universidad AutónomaRheumatology Division, Hospital de La Princesa, IIS-IP, Universidad AutónomaRheumatology Division, Hospital de La Princesa, IIS-IP, Universidad AutónomaRheumatology Division, Hospital de La Princesa, IIS-IP, Universidad Autónomahttp://link.springer.com/article/10.1186/s13075-017-1362-5
collection DOAJ
language English
format Article
sources DOAJ
author Santos Castañeda
Irene Llorente
Rosario García-Vicuña
Isidoro González-Álvaro
spellingShingle Santos Castañeda
Irene Llorente
Rosario García-Vicuña
Isidoro González-Álvaro
Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.
Arthritis Research & Therapy
author_facet Santos Castañeda
Irene Llorente
Rosario García-Vicuña
Isidoro González-Álvaro
author_sort Santos Castañeda
title Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.
title_short Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.
title_full Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.
title_fullStr Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.
title_full_unstemmed Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.
title_sort anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by bugatti et al.
publisher BMC
series Arthritis Research & Therapy
issn 1478-6362
publishDate 2017-07-01
url http://link.springer.com/article/10.1186/s13075-017-1362-5
work_keys_str_mv AT santoscastaneda anticitrullinatedproteinantibodiesandbonelossinpatientswithearlyarthritiscommentonthearticleanticitrullinatedproteinantibodiesandhighlevelsofrheumatoidfactorareassociatedwithsystemicbonelossinpatientswithearlyuntreatedrheumatoidarthritisbybugattietal
AT irenellorente anticitrullinatedproteinantibodiesandbonelossinpatientswithearlyarthritiscommentonthearticleanticitrullinatedproteinantibodiesandhighlevelsofrheumatoidfactorareassociatedwithsystemicbonelossinpatientswithearlyuntreatedrheumatoidarthritisbybugattietal
AT rosariogarciavicuna anticitrullinatedproteinantibodiesandbonelossinpatientswithearlyarthritiscommentonthearticleanticitrullinatedproteinantibodiesandhighlevelsofrheumatoidfactorareassociatedwithsystemicbonelossinpatientswithearlyuntreatedrheumatoidarthritisbybugattietal
AT isidorogonzalezalvaro anticitrullinatedproteinantibodiesandbonelossinpatientswithearlyarthritiscommentonthearticleanticitrullinatedproteinantibodiesandhighlevelsofrheumatoidfactorareassociatedwithsystemicbonelossinpatientswithearlyuntreatedrheumatoidarthritisbybugattietal
_version_ 1716756271412019200